Renaissance Technologies LLC Has $7.28 Million Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Renaissance Technologies LLC reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 37.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 383,353 shares of the medical instruments supplier's stock after selling 226,605 shares during the period. Renaissance Technologies LLC owned approximately 0.19% of DENTSPLY SIRONA worth $7,276,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Riverview Trust Co bought a new position in DENTSPLY SIRONA during the 4th quarter worth about $26,000. MassMutual Private Wealth & Trust FSB grew its position in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 1,232 shares in the last quarter. UMB Bank n.a. grew its stake in DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after purchasing an additional 564 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after buying an additional 1,568 shares in the last quarter. Finally, Signaturefd LLC increased its holdings in DENTSPLY SIRONA by 513.3% during the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock worth $84,000 after buying an additional 3,706 shares during the last quarter. Institutional investors own 95.70% of the company's stock.

Insider Activity

In related news, Director Gregory T. Lucier bought 15,142 shares of the business's stock in a transaction on Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 0.52% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Stock Up 1.4 %

Shares of XRAY opened at $12.83 on Friday. The firm has a 50 day simple moving average of $15.72 and a two-hundred day simple moving average of $18.82. The company has a market cap of $2.56 billion, a P/E ratio of -6.20, a P/E/G ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $31.00. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.99%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.07%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on XRAY. Mizuho lowered their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research note on Thursday, March 13th. Morgan Stanley lowered DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a report on Tuesday. Robert W. Baird reduced their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Friday, February 28th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Finally, Jefferies Financial Group cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their price target for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Thirteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA has an average rating of "Hold" and a consensus target price of $22.58.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.